Financhill
Sell
39

CHDN Quote, Financials, Valuation and Earnings

Last price:
$132.24
Seasonality move :
1.21%
Day range:
$131.68 - $135.04
52-week range:
$111.10 - $150.21
Dividend yield:
0.31%
P/E ratio:
24.09x
P/S ratio:
3.70x
P/B ratio:
8.86x
Volume:
843.8K
Avg. volume:
428.4K
1-year change:
1.35%
Market cap:
$9.7B
Revenue:
$2.5B
EPS (TTM):
$5.49

Earnings Data

Next earnings date for CHDN
Feb 21
2025
Most recent earnings per share
$0.86
Missed by $0.19
(Oct 23/2024)
Consensus Estimate
$1.05
(Oct 23/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHDN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $620.3M -- -- $0.97 --
10/23/2024 Q3 $628.4M $628.5M $0.86 $1.05 -$0.19
07/24/2024 Q2 $858.7M $890.7M $2.79 $2.70 $0.09
04/24/2024 Q1 $565.9M $590.9M $1.08 $0.83 $0.25
02/21/2024 Q4 $553M $561.2M $0.76 $0.77 -$0.01
10/25/2023 Q3 -- -- $0.79 $0.86 -$0.07
07/26/2023 Q2 -- -- $1.86 $2.51 -$0.65
04/26/2023 Q1 -- -- $2.05 $0.90 $1.15
02/22/2023 Q4 -- -- $0.02 $0.90 -$0.88
10/26/2022 Q3 -- -- $0.74 $0.79 -$0.05
07/27/2022 Q2 -- -- $4.39 $2.00 $2.39
04/27/2022 Q1 -- -- $0.54 -- --
02/23/2022 Q4 -- -- $0.56 -- --
10/27/2021 Q3 -- -- $0.79 -- --
07/28/2021 Q2 -- -- $1.38 -- --
04/21/2021 Q1 -- -- $0.46 -- --
02/24/2021 Q4 -- -- $0.22 -- --
10/28/2020 Q3 -- -- $0.54 -- --
07/29/2020 Q2 -- -- -$1.50 -- --
04/29/2020 Q1 -- -- -$0.30 -- --
02/26/2020 Q4 -- -- $0.05 -- --
10/30/2019 Q3 -- -- $0.18 -- --
07/31/2019 Q2 -- -- $1.32 -- --
04/24/2019 Q1 -- -- $0.15 -- --
02/27/2019 Q4 -- -- $0.14 -- --
10/31/2018 Q3 -- -- $0.69 -- --
08/01/2018 Q2 -- -- $1.26 -- --
04/25/2018 Q1 -- -- $2.09 -- --
02/28/2018 Q4 -- -- $0.41 -- --
11/01/2017 Q3 -- -- $0.18 -- --
07/26/2017 Q2 -- -- $0.80 -- --
04/26/2017 Q1 -- -- $0.07 -- --
02/28/2017 Q4 -- -- $0.27 -- --
10/27/2016 Q3 -- -- $0.09 -- --
08/03/2016 Q2 -- -- $0.69 -- --
04/28/2016 Q1 -- -- $0.03 -- --
02/25/2016 Q4 -- -- $0.07 -- --
10/29/2015 Q3 -- -- $0.04 -- --
07/29/2015 Q2 -- -- $0.52 -- --
04/27/2015 Q1 -- -- -$0.02 -- --
02/26/2015 Q4 -- -- -$0.14 -- --

Churchill Downs Earnings Questions

  • How Much did Churchill Downs Generate in Revenue Last Quarter?

    Churchill Downs reported $628.5M worth of top line sales in its most recent quarter.

  • Did Churchill Downs Beat Earnings Last Quarter?

    Churchill Downs announced earnings per share of $0.86 which represents a miss of analyst forecast a $1.05 per share.

  • Is Churchill Downs Profitable?

    Churchill Downs reported $185.6M that represents $2.49 per share over the last quarter.

  • What is the Analyst Consensus for Churchill Downs EPS Next Year?

    Churchill Downs's earnings are forecast to grow from $5.49 per share to $4.98 per share next year representing an increase of 7.01%.

  • When is Churchill Downs's Earnings Date?

    Churchill Downs's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock